KARL STORZ and Saphena Medical Partnership

RAYUS Radiology Quality Institute Distinguished Nationally by Centers for Medicare & Medicaid

Quality Institute Again Earns Certification as Provider-Led Entity for Advanced Diagnostic Imaging Guidance to Clinicians.

LX1550 Multiparameter Remote Monitoring Platform Receives FDA 510 (k) Approval: Reports LifeSignals

Further validation of ability to deliver continuous remote patient vital signs monitoring within both hospital and home settings.

U.S. News & World Report Names Tampa General Hospital as Best in Tampa Bay

This is the sixth consecutive year that Tampa General has been named by U.S. News & World Report as Tampa Bay's top hospital.

Today KARL STORZ Endoscopy-America, Inc., announced a new partnership with Saphena Medical to provide advanced instruments for endoscopic vessel harvesting (EVH).

EVH is a revolutionary procedure that enables surgeons to obtain grafts for coronary bypass using a keyhole approach, without lengthy incisions. Dr. Albert Chin, the co-founder of Saphena Medical, pioneered the technology, which has enjoyed rapid and widespread adoption in the field. The introduction of Saphena’s Venapax® device represented a major advance by enabling the surgeon to dissect, ligate, and extract a vessel with a single instrument.

The 4th generation Venapax has been specifically constructed with a reinforced shaft and internal guides to fit a KARL STORZ telescope. It allows for a simplified radial artery or saphenous vein harvesting with a shortened learning curve and a drastically reduced overall disposable cost. The partnership began with a pilot program at five hospitals and will continue to expand on a phased basis.

“We are excited to join forces with such a dynamic and innovative partner. Our expertise in endoscopic imaging—which includes considerable experience in the cardiothoracic market—makes us the logical choice for advancing this EVH technology,” said Monica Ambrose, Executive Director of Surgical Marketing at KARL STORZ.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.